We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$481B
AUM Growth
+$34.6B
Cap. Flow
+$38.1B
Cap. Flow %
7.92%
Top 10 Hldgs %
29.35%
Holding
15,428
New
1,885
Increased
5,794
Reduced
5,768
Closed
1,724

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.26B
2
MSFT icon
Microsoft
MSFT
+$633M
3
BABA icon
Alibaba
BABA
+$501M
4
ATVI
Activision Blizzard
ATVI
+$484M
5
AAPL icon
Apple
AAPL
+$456M

Sector Composition

Rank Sector Weight
1 Technology 3.08%
2 Consumer Discretionary 2.25%
3 Financials 2.23%
4 Healthcare 2.22%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABEO icon
13601
Abeona Therapeutics
ABEO
$341M
-2,143
Closed -$83K
ABEO icon
13602
PUT
Abeona Therapeutics
ABEO
$341M
-2,324
Closed -$91K
ACA icon
13603
CALL
Arcosa
ACA
$7.14B
-5,500
Closed -$323K
ACGL icon
13604
CALL
Arch Capital
ACGL
$33.7B
-32,700
Closed -$1.27M
ACEL icon
13605
PUT
Accel Entertainment
ACEL
$1.01B
-31,200
Closed -$370K
ACIC icon
13606
PUT
American Coastal Insurance
ACIC
$466M
-17,900
Closed -$102K
ACRE
13607
Ares Commercial Real Estate
ACRE
$262M
-185,951
Closed -$2.82M
ACTV
13608
DELISTED
LeaderShares Activist Leaders ETF
ACTV
-6,229
Closed -$242K
ACWV icon
13609
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.38B
-60,922
Closed -$6.27M
ADCT icon
13610
CALL
ADC Therapeutics
ADCT
$128M
-15,300
Closed -$373K
ADCT icon
13611
PUT
ADC Therapeutics
ADCT
$128M
-27,000
Closed -$657K
ADFI
13612
DELISTED
Anfield Dynamic Fixed Income ETF
ADFI
-12,249
Closed -$119K
ADM icon
13613
Archer Daniels Midland
ADM
$38.8B
-146,304
Closed -$8.77M
ADIL
13614
Adial Pharmaceuticals
ADIL
$8.71M
-32
Closed -$52K
ADNT icon
13615
Adient
ADNT
$1.57B
-48,171
Closed -$1.92M
ADTN icon
13616
CALL
Adtran
ADTN
$684M
-13,100
Closed -$271K
ADV icon
13617
CALL
Advantage Solutions
ADV
$420M
-1,348
Closed -$364K
ADV icon
13618
PUT
Advantage Solutions
ADV
$420M
-464
Closed -$125K
AFYA icon
13619
CALL
Afya
AFYA
$1.27B
-12,600
Closed -$325K
AFYA icon
13620
Afya
AFYA
$1.27B
-17,026
Closed -$439K
AGL icon
13621
CALL
Agilon Health
AGL
$1.63B
-392
Closed -$398K
AGM.A icon
13622
Federal Agricultural Mortgage Class A
AGM.A
$1.79B
-2,608
Closed -$236K
AGOX icon
13623
Adaptive Alpha Opportunities ETF
AGOX
$391M
-14,235
Closed -$373K
AGX icon
13624
PUT
Argan
AGX
$8.11B
-6,800
Closed -$325K
AGS
13625
CALL
DELISTED
PlayAGS
AGS
-11,900
Closed -$118K

Similar funds

Ken Griffin's Q3 2021 Portfolio in Review

As of Q3 2021, Ken Griffin held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ken Griffin deployed $38.1B of net new capital in Q3 2021, opening 1,885 new positions and adding to 5,794 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, down from 3.2% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.

  • Ken Griffin's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
  • Ken Griffin added most to Tesla in Q3 2021, an estimated $1.26B increase.
  • Ken Griffin's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
  • Ken Griffin fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
  • Ken Griffin's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
  • Ken Griffin opened 1,885 new positions and closed 1,724 in Q3 2021.
  • Ken Griffin's portfolio value rose 7.8% quarter-over-quarter to $481B.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.